comparemela.com
Home
Live Updates
MedMira, Inc.: Point-of-Care Diagnostic for Trichomonas Vaginalis Based on MedMiras RVF Technology : comparemela.com
MedMira, Inc.: Point-of-Care Diagnostic for Trichomonas Vaginalis Based on MedMira's RVF Technology
HALIFAX, NS / ACCESSWIRE / January 3, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the publication of Point-of-Care Diagnostic for Trichomonas vaginalis, the Most Prevalent, Non-Viral Sexually
Related Keywords
China ,
United States ,
Canada ,
Switzerland ,
Americans ,
Swiss ,
John Alderete ,
Markus Meile ,
Hermes Chan ,
Washington State University ,
Linkedin ,
Twitter ,
Medmira Inc ,
School Of Molecular Biosciences ,
European Union ,
Medmira Inc View ,
Venture Exchange ,
Regulation Services Provider ,
Point Of Care Diagnostic ,
Most Prevalent ,
Non Viral Sexually Transmitted Infection ,
Professor John Alderete ,
Molecular Biosciences ,
Miriad Rapid Vertical Flow Assay Toolkit ,
Sexually Transmitted Infections ,
African Americans ,
New Year ,
Medmira Rapid Vertical Flow ,
Rapid Vertical ,
Nova Scotia ,
Inc View ,
Medmira ,
Joint ,
Mare ,
Iagnostic ,
Trichomonas ,
Aginalis ,
Ased ,
Technology ,
comparemela.com © 2020. All Rights Reserved.